|
1
|
The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.
|
Clin Infect Dis
|
2006
|
13.01
|
|
2
|
A critical appraisal of "chronic Lyme disease".
|
N Engl J Med
|
2007
|
7.84
|
|
3
|
Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.
|
Ann Intern Med
|
2002
|
3.41
|
|
4
|
Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans.
|
Clin Infect Dis
|
2013
|
3.36
|
|
5
|
Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.
|
J Infect Dis
|
2003
|
3.18
|
|
6
|
Antiscience and ethical concerns associated with advocacy of Lyme disease.
|
Lancet Infect Dis
|
2011
|
2.88
|
|
7
|
Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis.
|
Arthritis Rheum
|
2008
|
2.45
|
|
8
|
Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis.
|
Arthritis Rheum
|
2007
|
2.20
|
|
9
|
A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi.
|
Infect Immun
|
2008
|
2.15
|
|
10
|
Case records of the Massachusetts General Hospital. Case 11-2007. A 59-year-old man with neck pain, weakness in the arms, and cranial-nerve palsies.
|
N Engl J Med
|
2007
|
2.11
|
|
11
|
Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe.
|
Clin Infect Dis
|
2013
|
1.82
|
|
12
|
Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis.
|
Arthritis Rheum
|
2012
|
1.79
|
|
13
|
Reinfection versus relapse in Lyme disease.
|
N Engl J Med
|
2012
|
1.70
|
|
14
|
Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease.
|
J Clin Microbiol
|
2006
|
1.66
|
|
15
|
Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
|
Clin Infect Dis
|
2011
|
1.49
|
|
16
|
Borrelia burgdorferi stimulation of chemokine secretion by cells of monocyte lineage in patients with Lyme arthritis.
|
Arthritis Res Ther
|
2010
|
1.46
|
|
17
|
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.
|
Diagn Microbiol Infect Dis
|
2012
|
1.45
|
|
18
|
The presenting manifestations of Lyme disease and the outcomes of treatment.
|
N Engl J Med
|
2003
|
1.45
|
|
19
|
Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis.
|
Arthritis Rheum
|
2011
|
1.44
|
|
20
|
Duration of antibiotic therapy for Lyme disease.
|
Ann Intern Med
|
2003
|
1.39
|
|
21
|
High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory lyme arthritis.
|
Arthritis Rheum
|
2007
|
1.37
|
|
22
|
Searching for borrelial T cell epitopes associated with antibiotic-refractory Lyme arthritis.
|
Mol Immunol
|
2008
|
1.30
|
|
23
|
Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease.
|
Am J Pathol
|
2011
|
1.21
|
|
24
|
Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis.
|
Mol Immunol
|
2007
|
1.20
|
|
25
|
2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test.
|
Clin Infect Dis
|
2010
|
1.15
|
|
26
|
A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease.
|
Arthritis Rheum
|
2013
|
1.15
|
|
27
|
Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis.
|
Arthritis Rheum
|
2010
|
1.11
|
|
28
|
Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma.
|
Infect Immun
|
2007
|
1.11
|
|
29
|
Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease.
|
J Infect Dis
|
2003
|
1.09
|
|
30
|
Higher mRNA levels of chemokines and cytokines associated with macrophage activation in erythema migrans skin lesions in patients from the United States than in patients from Austria with Lyme borreliosis.
|
Clin Infect Dis
|
2008
|
1.06
|
|
31
|
The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis.
|
Otol Neurotol
|
2004
|
1.05
|
|
32
|
Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis.
|
Infect Immun
|
2005
|
1.04
|
|
33
|
Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis.
|
Arthritis Rheum
|
2009
|
1.02
|
|
34
|
Inflammatory cytokine production predominates in early Lyme disease in patients with erythema migrans.
|
Infect Immun
|
2003
|
1.02
|
|
35
|
Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii.
|
J Infect Dis
|
2009
|
1.01
|
|
36
|
Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis.
|
Arthritis Res Ther
|
2013
|
0.99
|
|
37
|
Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis.
|
Mol Cell Proteomics
|
2010
|
0.98
|
|
38
|
Multiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics.
|
Clin Vaccine Immunol
|
2011
|
0.97
|
|
39
|
Dysregulation of CD4+CD25(high) T cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritis.
|
Arthritis Rheum
|
2013
|
0.93
|
|
40
|
Human Lyme arthritis and the immunoglobulin G antibody response to the 37-kilodalton arthritis-related protein of Borrelia burgdorferi.
|
Infect Immun
|
2005
|
0.93
|
|
41
|
Decline in the frequencies of Borrelia burgdorferi OspA161 175-specific T cells after antibiotic therapy in HLA-DRB1*0401-positive patients with antibiotic-responsive or antibiotic-refractory lyme arthritis.
|
J Immunol
|
2007
|
0.92
|
|
42
|
Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato.
|
J Autoimmun
|
2004
|
0.90
|
|
43
|
Strong IgG antibody responses to Borrelia burgdorferi glycolipids in patients with Lyme arthritis, a late manifestation of the infection.
|
Clin Immunol
|
2009
|
0.89
|
|
44
|
Role of aggrecanase 1 in Lyme arthritis.
|
Arthritis Rheum
|
2006
|
0.88
|
|
45
|
Antibodies to endothelial cell growth factor and obliterative microvascular lesions in the synovium of patients with antibiotic-refractory lyme arthritis.
|
Arthritis Rheumatol
|
2014
|
0.87
|
|
46
|
In situ diversification of the antibody repertoire in chronic Lyme arthritis synovium.
|
J Immunol
|
2005
|
0.87
|
|
47
|
Natural killer cells and natural killer T cells in Lyme arthritis.
|
Arthritis Res Ther
|
2013
|
0.85
|
|
48
|
Case records of the Massachusetts General Hospital. Case 14-2005. A 38-year-old man with fever and blurred vision.
|
N Engl J Med
|
2005
|
0.78
|
|
49
|
Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.
|
J Infect Dis
|
2007
|
0.78
|
|
50
|
Differences in Genotype, Clinical Features, and Inflammatory Potential of Borrelia burgdorferi sensu stricto Strains from Europe and the United States.
|
Emerg Infect Dis
|
2016
|
0.77
|
|
51
|
Tick-specific borrelial antigens appear to be upregulated in American but not European patients with Lyme arthritis, a late manifestation of Lyme borreliosis.
|
J Infect Dis
|
2013
|
0.76
|
|
52
|
Cerebellar ataxia as the presenting manifestation of Lyme disease.
|
Pediatr Infect Dis J
|
2002
|
0.76
|
|
53
|
Reinfection versus relapse in Lyme disease.
|
N Engl J Med
|
2013
|
0.75
|
|
54
|
Role of adrenomedullin in Lyme disease.
|
Infect Immun
|
2010
|
0.75
|
|
55
|
Reply to letter by Volkman commenting on the possible onset of seronegative disease in Lyme arthritis.
|
Arthritis Rheum
|
2009
|
0.75
|
|
56
|
Reply to Parvu and Parvu.
|
Clin Infect Dis
|
2014
|
0.75
|
|
57
|
Correction: Lyme borreliosis.
|
Nat Rev Dis Prim
|
2017
|
0.75
|